Clinical Implications of Inflammation in Patients With Cirrhosis
Author Information
Author(s): Victoria T. Kronsten, Debbie L. Shawcross
Primary Institution: King's College London
Hypothesis
Systemic inflammation plays a crucial role in the disease course of cirrhosis and is a key driver for acute decompensation and the progression from compensated to decompensated cirrhosis.
Conclusion
Systemic inflammation is fundamental to the development of organ dysfunction and failure in cirrhosis, and its severity is closely related to prognosis.
Supporting Evidence
- Systemic inflammation is a key driver for acute decompensation and the progression from compensated to decompensated cirrhosis.
- Patients with the most profound systemic inflammation have the worst prognosis.
- Systemic inflammation correlates with bacterial translocation, liver disease severity, and organ failure.
Takeaway
Cirrhosis can cause inflammation in the body, which makes patients sicker and can lead to serious problems like organ failure. The more inflammation there is, the worse the outcome.
Methodology
The PREDICT study was a European prospective observational study of patients with acute decompensation of cirrhosis.
Limitations
Further work is required to fully understand the mechanisms of systemic inflammation in cirrhosis.
Participant Demographics
Patients with acute decompensation of cirrhosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website